What does Cellectis S.A. do?

Cellectis S.A. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in I0. It is registered with the SEC under CIK 0001627281 and trades on NASDAQ under the ticker CLLS.

How many SEC filings has Cellectis S.A. made?

Cellectis S.A. has filed 512 documents with the SEC since 2014. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Cellectis S.A.

CLLS NASDAQ CIK: 0001627281 Biological Products, (No Diagnostic Substances) Inc. in I0

View on SEC.gov →

Overview All Filings Financials Insiders

Recent Filings

All 512 filings →

Form	Description	Date
6-K	FORM 6-K	Mar 20, 2026
20-F	20-F	Mar 20, 2026
6-K	FORM 6-K	Mar 12, 2026
6-K	FORM 6-K	Jan 8, 2026
6-K	FORM 6-K	Dec 15, 2025
SCHEDULE 13D/A	—	Dec 12, 2025
6-K	FORM 6-K	Dec 8, 2025
6-K	6-K	Dec 5, 2025
6-K	FORM 6-K	Nov 19, 2025
6-K	6-K	Nov 7, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Cellectis S.A.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001627281
Ticker: CLLS
Exchange: NASDAQ
Incorporated: I0
First Filing: 2014
Total Filings: 512